RenovaCare, Inc. Announces Resignation of Jatinder S. Bhogal as Chief Operating Officer
July 08, 2020 at 02:29 am IST
Share
RenovaCare, Inc. announced Mr. Jatinder S. Bhogal resigned as the Company's Chief Operating Officer in order to pursue other business opportunities, effective July 1, 2020; however, Mr. Bhogal will continue to act, on a limited basis, as a consultant to the Company, especially with respect to legacy matters. Mr. Bhogal's resignation was not based on any policy disagreements between Mr. Bhogal and the Company.
RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patientâs own cells) cellular therapies that can be used for medical and aesthetic applications. The Companyâs CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patientâs own skin or other tissues. The resulting stem cell suspension is administered topically from the Companyâs novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.
RENOVACARE, INC. 
